Pseudobulbar affect: an under-recognized and under-treated neurological disorder
- 3k Downloads
Pseudobulbar affect (PBA) is a neurologic syndrome of emotional affect disinhibition, characterized by uncontrollable, exaggerated, and often inappropriate emotional outbursts, which may cause severe distress, embarrassment, and social dysfunction. However, the US prevalence of PBA remains unknown.
An online survey was conducted primarily to estimate the US prevalence of PBA in patients with the six most commonly associated conditions: Alzheimer’s disease, amyotrophic lateral sclerosis, multiple sclerosis, Parkinson’s disease, stroke, and traumatic brain injury. Invitations to participate were randomly sent online to adults (aged ≥18 years) registered in the Harris Poll Online Panel who were patients or belonged to a household with a patient diagnosed with one of the six conditions (identified through previous screening by Harris Interactive). Participants were screened for PBA using the Pathological Laughing and Crying Scale (PLACS) and the Center for Neurologic Study-Lability Scale (CNS-LS). PBA estimates were made using a cut-off score of ≥13 on the PLACS and two different cut-off thresholds on the CNS-LS, a lower one of ≥13 and a more rigorous one of ≥21. Existing US prevalence data for the six underlying conditions were used to estimate US prevalence of PBA.
Of 38,000 individuals invited to participate, 8876 responded (23%) and 2318 (26%) completed the questionnaire. Mean prevalence of PBA across all six conditions was 10.1%, 9.4%, and 37.5% with the PLACS ≥13, CNS-LS ≥21, and CNS-LS ≥13 thresholds, respectively. Using disease population estimates from government agencies and professional organizations, the estimated US population with PBA ranged from 1.8 to 7.1 million. Among patients who discussed their laughing and/or crying episodes with a physician, 41% were diagnosed, and about half received a medication for their episodes.
The overall prevalence of PBA was estimated to be about 10% across these commonly associated underlying neurological conditions and appears to be under-recognized.
KeywordsAlzheimer’s disease amyotrophic lateral sclerosis diagnosis multiple sclerosis Parkinson’s disease prevalence pseudobulbar affect stroke traumatic brain injury treatment
- 6.Duda JE. History and prevalence of involuntary emotional expression disorder. CNS Spect. 2007;12(suppl. 5):6–10.Google Scholar
- 16.Miller RG, Rosenberg JA, Gelinas GF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52:1311–1323.PubMedGoogle Scholar
- 19.Ziegler LH. Psychotic and emotional phenomena, associated with amyotrophic lateral sclerosis. Arch Neurol Psychiatry. 1930;24:930–936.Google Scholar
- 23.Data on file. Avanir Pharmaceuticals, Inc.; 2006.Google Scholar
- 25.Langworthy OR, Kolb LC, Androp S. Disturbances of behavior in patients with disseminated sclerosis. Am J Psychiatry. 1941;98:243–249.Google Scholar
- 34.Faul M, Xu L, Wald MM, Coronado VG. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002–2006. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2010.Google Scholar
- 37.Smith RA, Licht JM, Pope LE, Berg JE, Arnold RP. Combination dextromethorphan and quinidine in the treatment of frustration and anger in patients with involuntary emotional expression disorder (IEED). Ann Neurol. 2006; 60(suppl. 3):S50.Google Scholar
- 38.The ALS Association. Who gets ALS? http://www.alsa.org/als/who.cfm. Accessed February 2, 2010.
- 39.National Institute of Neurological Disorders and Stroke (NINDS). Dementia: hope through research. http://www.ninds.nih.gov/disorders/dementias/detail_dementia.htm. Accessed February 2, 2010.
- 40.National MS Society. About MS: who gets MS? http://www.nationalmssociety.org/about-multiplesclerosis/what-we-know-about-ms/who-gets-ms/index.aspx. Accessed February 2, 2010.
- 41.Parkinson’s Disease Foundation. Frequently-asked questions about Parkinson’s disease. http://www.pdf.org/en/pins_res_center. Accessed February 2, 2010.
- 42.American Stroke Association. Heart disease and stroke statistics — 2005 update. http://www.americanheart.org/downloadable/heart/1105390918119HDSStats2005Update.pdf. Accessed March 23, 2011.
- 43.Centers for Disease Control (CDC) and National Center for Injury Prevention and Control (NCIPC). What are the long-term outcomes of TBI? 2006. http://www.cdc.gov/traumaticbraininjury/outcomes.html. Accessed February 2, 2010.
- 44.Wallin MT, Kurtzke JF. Neuroepidemiology. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, eds. Neurology in Clinical Practice. 4th edition. Philadelphia, PA: Butterworth Heinemann Elsevier, 2004:776–779.Google Scholar
- 45.United States Census Bureau. The Population Division of the United States Census Bureau. U.S. POPClock projection. http://www.census.gov/population/www/popclockus.html. Accessed February 2, 2010.
- 46.Rowland LP. Neurology in Clinical Practice, 3rd edition. Arch Neurol. 2000;57:1084.Google Scholar
- 47.Hier DB. Neurology in Clinical Practice e-dition: text with continually updated online references/Edition 4. Doody Review Services. http://search.barnesandnoble.com/Neurology-in-Clinical-Practicee-dition/Walter-G-Bradley/e/9780750674690#TABS. iAccessed January 6, 2011.
- 50.Langlois JA, Rutland-Brown W, Thomas KE. Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2004.Google Scholar
- 52.Miller RG, Anderson Brooks BR, Mitsumoto H, Bradley WG, Ringel, SP, for the ALS CARE Study Group. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the Amyotrophic Lateral Sclerosis Clinical Assessment, Research, and Education Database. Ann Neurol. 2009;65(suppl.):S 24–S28.Google Scholar
- 55.Poeck K. Pathological laughter and crying. In: Fredericks JAM, ed. Handbook of Clinical Neurology. Volume 45. Amsterdam, Netherlands: Elsevier Science Publishers; 1985.Google Scholar
- 69.Nuedexta™ (dextromethorphan hydrobromide and quinidine sulfate) capsules prescribing information. Aliso Viejo, CA: Avanir Pharmaceuticals, Inc.; October 2010.Google Scholar